SROs
Revised Regulatory Fee for Therapeutic Goods
Exemption for Import of Unregistered Drugs for use in Hospital and Institutions
Amendment in the Drugs (Licensing, Registering and Advertising) Rules, 1976 (S.R.O 1047(I)/2025)
Amendment in Medical Devices Rules, 2017 (S.R.O 1049(I)/2025)
Drugs Research Rules 1978 (Amended)
Notification regarding amendments in the Drugs (Research) Rules (S.R.O 168(I)/2025)
Notification regarding Therapeutic Goods (Advertisement) Rules, 2025
S.R.O. 1324(l)12024 – Revision of Regulatory Fee Notification
In exercise of the powers conferred by sub-section (1) of section 20 of the Drug Regulatory Authority of Pakistan Act,2012 (XXI of 2012), read with sub-rule (3) of Rule 4 of the Drug Regulatory Authority of Pakistan (Fee and Levy) Rules, 2022, the regulatory fees of various functions has been notified. The Notification as under:-